Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
assays
MedTech
Beckman Coulter grows Alzheimer’s dx portfolio with CE mark
Beckman Coulter expanded its portfolio of Alzheimer’s disease diagnostics by earning a CE mark in Europe for its Access p-Tau217 assay.
Joseph Keenan
Jul 7, 2026 10:55am
Thermo Fisher launches biopsy test to assess lung rejection risk
Oct 9, 2025 10:50am
Merck KGaA rolls out ‘all-in-one’ CHO genetic stability assay
Apr 18, 2024 4:05pm
Alzheimer's test could diagnose 'disease of exclusion' earlier
Dec 6, 2022 11:25am
Worldwide CRO expands with new bioanalytical lab
Aug 23, 2022 8:35am
PPD expands lab test work to boost pandemic trials
Jun 29, 2020 7:35am
